Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia.

Abstract excerpt

In a retrospective study, we analyzed the prevalence of common cardiovascular comorbidities in 310 patients with chronic myelomonocytic leukemia (CMML), their potential prognostic impact, and potential correlations with laboratory and molecular features. 115 (36%) patients had a documented cardiovascular comorbidity. In these patients, coronary heart disease 41/115 (36%), atrial fibrillation 34/115 (29%), and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Comorbidity
• Share to Leukemia, Myelomonocytic, Chronic
• Share to Mutation